The study, published in Food Science of Animal Resources, used a whey-derived milk polar lipid concentrate containing at least 25 percent total phospholipids, including sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Male C57BL/6J mice, a standard strain in metabolic research, were divided into four groups of six animals each. One group received a standard control diet, a second received a high-fat high-sucrose diet deriving 43 percent of its calories from fat and 24 percent from sucrose, a third received that same obesogenic diet modified so that milk fat was replaced with 8 percent of the milk polar lipid concentrate, and a fourth received the obesogenic diet supplemented with 0.01 percent orlistat, the pancreatic lipase inhibitor sold commercially as Xenical, serving as a positive control. The animals were followed for twelve weeks, with body weight and food intake recorded weekly and body composition assessed by dual-energy X-ray absorptiometry shortly before the study’s end.

The results were striking. Mice on the high-fat high-sucrose diet gained substantially more weight than controls, but the animals receiving milk polar lipids ended the study at a final body weight statistically indistinguishable from the normal-diet group. Fat mass, measured by DEXA scanning, was significantly lower in the supplemented animals, and the treatment partially restored lean mass while also improving bone mineral content, an intriguing secondary observation that suggests the lipids may help preserve skeletal status under metabolic stress. Food and calorie intake rose gradually in the unsupplemented high-fat group, but the researchers attributed this to increasing body mass rather than heightened appetite, noting that intake did not differ across groups during the early weeks when body weights were still comparable.

Blood chemistry told a similar story of protection. The obesogenic diet drove up total cholesterol and low-density lipoprotein cholesterol, both well-established indicators of dysregulated lipid metabolism, and elevated alanine aminotransferase and aspartate aminotransferase, the two enzymes clinicians rely on most heavily to detect liver cell damage. Supplementation with the milk lipid concentrate pushed all of these markers back toward normal levels. Serum triglycerides, curiously, were actually higher in the supplemented group than in the unsupplemented high-fat group, but the authors interpret this not as a metabolic failure but as a sign of enhanced lipid mobilization and export from liver and fat stores into circulation, consistent with prior evidence that dietary phospholipids influence very-low-density lipoprotein assembly and hepatic lipid handling. They caution that the relatively short four-hour fast before tissue collection may have introduced postprandial effects and call for future studies measuring free fatty acids and hepatic VLDL secretion rates to clarify the point.

Under the microscope, the differences were unmistakable. Adipocytes in the high-fat group were markedly enlarged, a hallmark of adipose tissue dysfunction that fuels chronic low-grade inflammation and floods peripheral organs with excess free fatty acids. Both the milk lipid and orlistat groups showed significantly smaller adipocytes and reduced weights of inguinal and mesenteric white adipose tissue depots. In the liver itself, hematoxylin and eosin staining and Oil Red O staining revealed heavy fat infiltration in the high-fat group, while the supplemented animals showed dramatically reduced steatosis, lower liver weights, and significantly reduced hepatic triglyceride content. Earlier work had suggested that milk phospholipids partly work by interfering with micellar lipid solubilization in the intestine, reducing absorption and increasing fecal lipid excretion, but the tiny amounts of intact phospholipids recovered in feces in prior studies indicated the supplements themselves are efficiently absorbed, hinting that they must also act systemically after uptake.

That systemic action is where the new study makes its most technically interesting contribution. The researchers probed the hepatic Wnt/β-catenin pathway, an evolutionarily ancient signaling cascade best known for orchestrating embryonic development but increasingly recognized as a metabolic regulator. The obesogenic diet significantly suppressed key components of the pathway, reducing hepatic expression of the co-receptor LRP6 and the ligand Wnt3a. Supplementation with the milk lipids, and to a comparable degree orlistat, restored LRP6 and Wnt3a expression, but only the milk lipid diet significantly upregulated total β-catenin, the pathway’s central transcriptional effector. When Wnt signaling is active, stabilized β-catenin enters the nucleus and suppresses adipogenic transcriptional programs driven by PPARγ and C/EBPα, thereby limiting lipid storage. Consistent with that model, the supplemented animals showed significantly reduced expression of PPARγ and its downstream partners DGAT1 and PLIN2, which govern triglyceride synthesis and lipid droplet formation, along with reduced SREBP1 and the de novo lipogenesis enzymes ACC, SCD1, and FAS.

The authors propose a plausible biophysical explanation for how dietary lipids could touch this membrane-anchored pathway. Polar lipids can alter the composition of cellular membranes, and membrane phosphoinositide metabolism is known to be essential for LRP6 activation, with prior work showing that Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. Milk fat globule membrane supplementation has also been shown in lipidomic studies to enrich membranes in phosphatidylcholine and phosphatidylethanolamine. In other words, the phospholipids consumed in the diet may be incorporated into hepatic membranes in ways that sensitize the Wnt machinery, though the authors are careful to frame this as a plausible mechanism rather than a demonstrated one. Notably, milk-derived sphingomyelin has previously outperformed egg-derived sphingomyelin against hepatic steatosis, suggesting that the source and molecular composition of dietary lipids matter in ways the field is only beginning to map.

The second arm of the mechanism involves the gut microbiome, and here the study employed 16S rRNA gene sequencing of cecal contents processed through the DADA2 and QIIME pipelines. The obesogenic diet significantly reduced microbial alpha diversity, as measured by the Shannon index and phylogenetic diversity, and shifted the community structure into a cluster clearly separated from controls. The milk lipid group formed its own distinct cluster, separate from both the high-fat and orlistat groups, with PERMANOVA confirming significant separation between the supplemented and unsupplemented high-fat animals. Because the orlistat group’s microbiome remained similar to the high-fat group’s, the authors infer that the lipids’ microbial effects extend beyond simple inhibition of fat absorption. At the phylum level, supplementation partially reversed the diet-driven rise in Bacillota and boosted Verrucomicrobiota, the phylum housing Akkermansia muciniphila, a mucin-degrading bacterium celebrated for its associations with gut barrier integrity and metabolic health, and consistently depleted in patients with fatty liver disease and obesity.

Additional taxa shifts reinforced the picture. The high-fat diet enriched bile acid-resistant Lactobacillus and Limosilactobacillus species, a pattern previously linked to altered intestinal bile acid composition in fatty liver models, while the milk lipid diet selectively increased Akkermansia along with Romboutsia and members of the Christensenellaceae family, taxa reported to improve lipid metabolism partly through enhanced short-chain fatty acid production. Prior studies have shown that A. muciniphila supplementation attenuates hepatic steatosis and inflammation, modulates bile acid metabolism through the intestinal FXR-FGF15 axis, and enhances mitochondrial fatty acid oxidation via L-aspartate signaling along the gut-liver axis. The authors are appropriately measured about causality, emphasizing that their microbial findings show association rather than proof and that future work measuring microbial metabolites such as short-chain fatty acids and bile acids will be needed to close the loop.

Taken together, the study sketches a coordinated mechanism in which a single dietary component acts simultaneously on intracellular lipogenic signaling and on the ecology of the gut, offering a template for how food-derived bioactives might be engineered into functional ingredients for metabolic disease. The caveats are real: the work was conducted in mice, the intervention used a concentrated extract at a dose that would be difficult to translate directly to human diets, and the mechanistic links remain partly inferential. But with fatty liver disease affecting hundreds of millions of people and no approved pharmacological therapy for its early stages, the idea that the humble membrane lipids enveloping fat droplets in milk could simultaneously quiet a liver’s fat-building program and cultivate a healthier gut community is precisely the kind of convergent finding that could shape the next generation of nutritional interventions.

Subject of Research: Effects of dietary milk polar lipids on hepatic lipid accumulation, Wnt-PPARγ signaling, and gut microbiota in a mouse model of non-alcoholic fatty liver disease

Article Title: Dietary milk polar lipids ameliorate hepatic lipid accumulation through coordinated regulation of Wnt-PPARγ signaling and remodeling of the gut microbiota

Article References: Kim, H., Park, D., Kwon, Y.-J., & Imm, J.-Y. (2026). Dietary milk polar lipids ameliorate hepatic lipid accumulation through coordinated regulation of Wnt-PPARγ signaling and remodeling of the gut microbiota. Food Science of Animal Resources, 46(1), Article 83. https://doi.org/10.1007/s44463-026-00100-w

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00100-w

Keywords: milk polar lipids, non-alcoholic fatty liver disease, Wnt/beta-catenin signaling, PPARgamma, gut microbiota, Akkermansia muciniphila, sphingomyelin, hepatic steatosis, short-chain fatty acids, gut-liver axis, high-fat high-sucrose diet, milk fat globule membrane

MASH develops when excessive lipid accumulation in the liver triggers chronic inflammation, hepatocellular injury, and ultimately fibrosis, the scarring process that replaces functional tissue with rigid extracellular matrix. In Japan alone, several million individuals are estimated to be affected, and disease progression is tightly linked to obesity, diabetes, and dyslipidemia. When adipose tissue becomes inflamed, it floods the circulation with free fatty acids and pro-inflammatory cytokines, amplifying the hepatic inflammatory milieu. Yet while the broad role of lipid overload in liver disease is well established, the mechanisms by which individual fatty acid species contribute to fibrogenesis have remained frustratingly opaque.

Central to the new work is the concept of macrophage polarization, the remarkable plasticity of innate immune cells that allows them to shift between functionally distinct states. Resting M0 macrophages can polarize toward pro-inflammatory M1 phenotypes, driven by stimuli such as lipopolysaccharide and interferon-gamma and characterized by production of tumor necrosis factor-alpha and inducible nitric oxide synthase, or toward anti-inflammatory M2 phenotypes induced by interleukin-4 and interleukin-13, marked by expression of peroxisome proliferator-activated receptor gamma and other mediators of tissue repair and fibrosis. Because dysregulated macrophage polarization is a key determinant of chronic inflammatory diseases including MASH, the research team led by investigators at Osaka Metropolitan University set out to determine whether specific fatty acids could bias this process in cultured cells.

Using bone marrow-derived macrophages isolated from male Wistar rats, the researchers exposed cells to albumin-conjugated palmitic acid, oleic acid, or palmitoleic acid at non-cytotoxic concentrations of 0.1 and 0.2 millimolar while simultaneously polarizing them toward M1 or M2 states. The results were strikingly fatty acid-specific. Palmitic acid, the saturated species that accounts for roughly 31 percent of plasma free fatty acids, significantly increased Tnf mRNA and boosted both iNOS and TNF-alpha protein expression in M1 macrophages, effectively reinforcing their inflammatory profile. It also consistently suppressed PPARgamma, a master transcriptional regulator of alternative activation, in M2 macrophages. Because PPARgamma negatively constrains NF-kappaB-mediated inflammatory signaling, its suppression may tilt macrophages toward a more pro-inflammatory identity.

The unsaturated fatty acids told a different story. Oleic acid, which makes up approximately 27 percent of plasma free fatty acids, increased Nos2 and Tnf mRNA in resting and M2 macrophages, but these transcriptional changes never materialized into detectable protein, and their magnitude was trivial compared with genuine M1 induction. Nevertheless, oleic acid proved far from benign: it significantly enhanced reactive oxygen species production in M1 macrophages and reduced several M2-associated markers, including PPARgamma and Ym1. This context dependence is notable given previous reports of oleic acid’s anti-inflammatory effects mediated through the free fatty acid receptor FFAR4 and adiponectin-driven AMPK activation. Palmitoleic acid, the monounsaturated omega-7 species, displayed its own signature: it dampened iNOS protein expression and significantly suppressed ROS production in M1 macrophages, consistent with prior evidence that it can antagonize palmitate-induced inflammation through AMPK and TLR4-related mechanisms, yet it too reduced selected M2 markers.

Oxidative stress emerged as a central theme. Using the chemiluminescent probe L-012, the team measured superoxide generation in polarized macrophages and found that ROS production was markedly higher in M1 cells than in M0 or M2 counterparts, confirming that the inflammatory program is intrinsically linked to redox activity. Critically, fatty acid treatment had minimal effects on ROS in resting and M2 macrophages, but palmitic acid and oleic acid each significantly increased superoxide production in M1 macrophages, while palmitoleic acid significantly decreased it. Since the majority of detected ROS was superoxide, likely originating from mitochondria and NADPH oxidase complexes, the data suggest that palmitate-induced oxidative stress in inflammatory macrophages may involve NOX-dependent mechanisms, a hypothesis the authors note requires direct testing of TLR4 and NF-kappaB pathways in future work.

The researchers then turned to the other half of the fibrotic dialogue: hepatic stellate cells, which reside quiescently in the space of Disse storing vitamin A-laden lipid droplets until chronic injury drives them to activate, express alpha-smooth muscle actin, and deposit type I collagen. In a first series of experiments, direct treatment of primary rat stellate cells with any of the three fatty acids failed to alter alpha-SMA, cytoglobin, TGF-beta, or Col1a1 expression at either the mRNA or protein level, indicating that none of the tested lipids directly activates stellate cells under these conditions. This negative result is itself meaningful, redirecting attention from direct lipotoxicity toward immune-mediated indirect pathways.

When stellate cells were instead cultured in conditioned media harvested from fatty acid-treated polarized macrophages, the picture shifted. The dominant determinant of stellate cell marker expression was the macrophages’ polarization status rather than the fatty acid they had received. Conditioned media from M1 macrophages reduced both alpha-SMA and cytoglobin expression in stellate cells compared with media from resting M0 cells, and fatty acid-specific effects were modest and marker-dependent. Cytoglobin deserves particular attention: this antioxidant protein protects stellate cells by scavenging reactive oxygen species and maintaining redox homeostasis, and its reduction, as documented in previous studies of NASH, can weaken antioxidant defenses and heighten susceptibility to oxidative DNA damage. The authors therefore interpret their data as evidence that fatty acid-dependent macrophage reprogramming can secondarily modify stellate cell redox-related responses, without claiming that fatty acids directly drive stellate cell activation.

The study is not without limitations, which the authors candidly enumerate. TLR4-dependent signaling was not directly assessed, ROS measurements relied primarily on L-012 chemiluminescence rather than complementary probes, the entire system was in vitro and awaits validation in animal models of MASH, stellate cell activation was evaluated by marker expression rather than functional assays of proliferation, migration, and contractility, and some experiments employed relatively small numbers of biological replicates. The fatty acid concentrations chosen, 0.2 millimolar, were selected after preliminary cytotoxicity testing and sit below concentrations commonly used in the field, though local concentrations within the hepatic microenvironment may differ from systemic levels.

Even with these caveats, the work delivers a provocative message: lipid composition, not merely lipid quantity, is a meaningful determinant of immune-stromal interactions in the liver. By showing that a saturated fatty acid pushes macrophages toward inflammatory, ROS-generating phenotypes while a monounsaturated omega-7 species dampens them, and that these shifts ripple outward to alter antioxidant signaling in the cells that build scar tissue, the study sketches a plausible mechanism linking dietary fat quality to fibrogenic progression in metabolic liver disease. If confirmed in vivo, the findings could open new avenues for intervening in MASH not simply by reducing fat intake, but by reshaping the fatty acid milieu that instructs the immune system how to respond to it.

Subject of Research: Fatty acid species-dependent regulation of macrophage polarization, oxidative stress, and macrophage-hepatic stellate cell crosstalk in liver fibrosis.

Article Title: Fatty acid species differentially regulate macrophage polarization and oxidative stress with secondary effects on macrophage–HSC crosstalk

Article References: Nakanishi, K., Shinkawa, H., Takemura, S., Nakagawa, K., Minamiyama, Y., & Ishizawa, T. (2026). Fatty acid species differentially regulate macrophage polarization and oxidative stress with secondary effects on macrophage– HSC crosstalk. Physiological Reports, 14(17), Article e71082. https://doi.org/10.14814/phy2.71082

Image Credits: AI Generated

DOI: 10.14814/phy2.71082

Keywords: macrophage polarization, fatty acids, palmitic acid, oleic acid, palmitoleic acid, hepatic stellate cells, liver fibrosis, MASH, oxidative stress, PPARgamma, cytoglobin, TLR4